United Therapeutics Corp’s recent filing unveils that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.8
United Therapeutics Corp’s recent filing unveils that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.8
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. United Therapeutics
United Therapeutics Corp’s recent filing unveils that its FOUNDER, CHAIRPERSON, AND CHIE ROTHBLATT MARTINE A acquired Company’s shares for reported
United Therapeutics Corp’s recent filing unveils that its FOUNDER, CHAIRPERSON, AND CHIE ROTHBLATT MARTINE A acquired Company’s shares for reported
United Therapeutics Corp’s recent filing unveils that its FOUNDER, CHAIRPERSON, AND CHIE ROTHBLATT MARTINE A acquired Company’s shares for reported
United Therapeutics Corp’s filing revealed that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported $4.24
United Therapeutics Corp’s filing revealed that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported $3.4
United Therapeutics Corp’s recent filing unveils that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported
United Therapeutics Corp’s recently made public that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported